loadpatents
name:-0.16309905052185
name:-0.045549154281616
name:-0.026221036911011
Glick; Gary D. Patent Filings

Glick; Gary D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Glick; Gary D..The latest application filed is for "nlrp3 modulators".

Company Profile
24.55.80
  • Glick; Gary D. - Ann Arbor MI
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Nlrp3 Modulators
App 20220289736 - Glick; Gary D. ;   et al.
2022-09-15
Methods Of Treatment
App 20220105057 - Glick; Gary D.
2022-04-07
Methods Of Treatment
App 20220079897 - Glick; Gary D.
2022-03-17
Methods And Compositions For Treating Conditions Associated With An Abnormal Inflammatory Responses
App 20220000812 - Glick; Gary D. ;   et al.
2022-01-06
Methods And Compositions For Treating Conditions Associated With An Abnormal Inflammatory Response
App 20210401784 - Glick; Gary D. ;   et al.
2021-12-30
NLRP3 modulators
Grant 11,072,612 - Glick , et al. July 27, 2
2021-07-27
Methods and compositions for treating conditions associated with an abnormal inflammatory response
Grant 10,912,746 - Glick , et al. February 9, 2
2021-02-09
Methods and compositions for treating conditions associated with an abnormal inflammatory response
Grant 10,905,666 - Glick , et al. February 2, 2
2021-02-02
Methods and compositions for treating conditions associated with an abnormal inflammatory response
Grant 10,849,867 - Glick , et al. December 1, 2
2020-12-01
Methods and compositions for treating conditions associated with an abnormal inflammatory responses
Grant 10,799,468 - Glick , et al. October 13, 2
2020-10-13
Methods and compositions for treating conditions associated with an abnormal inflammatory response
Grant 10,772,854 - Glick , et al. Sept
2020-09-15
Methods And Compositions For Treating Conditions Associated With An Abnormal Inflammatory Responses
App 20200276140 - Glick; Gary D. ;   et al.
2020-09-03
Methods And Compositions For Treating Conditions Associated With An Abnormal Inflammatory Responses
App 20200268694 - Glick; Gary D. ;   et al.
2020-08-27
Methods and compositions for treating conditions associated with an abnormal inflammatory responses
Grant 10,744,103 - Glick , et al. A
2020-08-18
Methods And Compositions For Treating Conditions Associated With An Abnormal Inflammatory Responses
App 20200197339 - Glick; Gary D. ;   et al.
2020-06-25
Methods And Compositions For Treating Conditions Associated With An Abnormal Inflammatory Responses
App 20200197340 - Glick; Gary D. ;   et al.
2020-06-25
Nlrp3 Modulators
App 20200157096 - Glick; Gary D. ;   et al.
2020-05-21
Nlrp3 Modulators
App 20200157097 - Glick; Gary D. ;   et al.
2020-05-21
Methods And Compositions For Treating Conditions Associated With An Abnormal Inflammatory Responses
App 20200147013 - Glick; Gary D. ;   et al.
2020-05-14
Methods And Compositions For Treating Conditions Associated With An Abnormal Inflammatory Responses
App 20200147012 - Glick; Gary D. ;   et al.
2020-05-14
NLRP3 modulators
Grant 10,556,903 - Glick , et al. Feb
2020-02-11
NLRP3 modulators
Grant 10,533,007 - Glick , et al. Ja
2020-01-14
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods
Grant 10,532,088 - Glick , et al. Ja
2020-01-14
Cyclic Dinucleotide Analogs For Treating Conditions Associated With Sting (stimulator Of Interferon Genes) Activity
App 20190345191 - Glick; Gary D. ;   et al.
2019-11-14
Methods And Compositions For Treating Conditions Associated With An Abnormal Inflammatory Responses
App 20190298670 - Glick; Gary D. ;   et al.
2019-10-03
Methods and compositions for treating conditions associated with an abnormal inflammatory responses
Grant 10,292,951 - Glick , et al.
2019-05-21
Nlrp3 Modulators
App 20190127368 - Glick; Gary D. ;   et al.
2019-05-02
Nlrp3 Modulators
App 20190127367 - Glick; Gary D. ;   et al.
2019-05-02
Immune Cells Having Increased Immunity Or Resistance To An Immunosuppressive Cytokine And Use Of The Same
App 20190064146 - Glick; Gary D. ;   et al.
2019-02-28
Pyrazolyl Guanidine F1f0-atpase Inhibitors And Therapeutic Uses Thereof
App 20180334438 - Glick; Gary D. ;   et al.
2018-11-22
Pyrazolyl guanidine F.sub.1F.sub.0-ATPase inhibitors and therapeutic uses thereof
Grant 9,932,313 - Glick , et al. April 3, 2
2018-04-03
1,4-benzodiazepone-2,5-diones and related compounds with therapeutic properties
Grant 9,849,138 - Glick December 26, 2
2017-12-26
Pyrazolyl Guanidine F1f0-atpase Inhibitors And Therapeutic Uses Thereof
App 20170267643 - Glick; Gary D. ;   et al.
2017-09-21
Methods And Compositions For Treating Conditions Associated With An Abnormal Inflammatory Responses
App 20170056347 - Glick; Gary D. ;   et al.
2017-03-02
Immune Cells Having Increased Immunity Or Resistance To An Immunosuppressive Cytokine And Use Of The Same
App 20170056448 - Glick; Gary D. ;   et al.
2017-03-02
Pyrazolyl guanidine F.sub.1F.sub.0-ATPase inhibitors and therapeutic uses thereof
Grant 9,580,388 - Glick , et al. February 28, 2
2017-02-28
Adoptive Cellular Therapy Using an Agonist of Retinoic Acid Receptor-Related Orphan Receptor Gamma & Related Therapeutic Methods
App 20170007686 - Glick; Gary D. ;   et al.
2017-01-12
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of ROR.gamma. activity and the treatment of disease
Grant 9,512,111 - Glick , et al. December 6, 2
2016-12-06
Pyridonyl guanidine F.sub.1F.sub.0-ATPase inhibitors and therapeutic uses thereof
Grant 9,370,507 - Glick , et al. June 21, 2
2016-06-21
1,4-Benzodiazepone-2,5-Diones And Related Compounds With Therapeutic Properties
App 20160095866 - Glick; Gary D.
2016-04-07
Pyrazolyl Guanidine F1f0-atpase Inhibitors And Therapeutic Uses Thereof
App 20160039769 - Glick; Gary D. ;   et al.
2016-02-11
Pyridonyl Guanidine F1f0-atpase Inhibitors And Therapeutic Uses Thereof
App 20150335625 - Glick; Gary D. ;   et al.
2015-11-26
Pyrazolyl guanidine F.sub.1F.sub.0-atpase inhibitors and therapeutic uses thereof
Grant 9,139,532 - Glick , et al. September 22, 2
2015-09-22
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
Grant 9,126,978 - Glick September 8, 2
2015-09-08
Pyridonyl guanidine F.sub.1F.sub.0-ATPase inhibitors and therapeutic uses thereof
Grant 9,000,014 - Glick , et al. April 7, 2
2015-04-07
Methods And Compositions For Detecting Immune System Activation
App 20150031068 - Glick; Gary D. ;   et al.
2015-01-29
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
Grant 8,815,845 - Glick August 26, 2
2014-08-26
Therapeutic applications of pro-apoptotic benzodiazepines
Grant 8,809,323 - Glick , et al. August 19, 2
2014-08-19
1,4-benzodiazepine-2,5-diones with therapeutic properties
Grant 8,791,104 - Glick July 29, 2
2014-07-29
Benzodiazepinone compounds useful in the treatment of skin conditions
Grant 8,759,340 - Glick June 24, 2
2014-06-24
Compositions and methods for inhibiting the proliferation of cells
Grant 8,722,667 - Glick , et al. May 13, 2
2014-05-13
N-SULFONYLATED TETRAHYDROQUINOLINES AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
App 20140088094 - Glick; Gary D. ;   et al.
2014-03-27
Benzodiazepinone compounds and methods of treatment using same
Grant 8,673,897 - Glick , et al. March 18, 2
2014-03-18
Pyridonyl Guanidine F1f0-atpase Inhibitors And Therapeutic Uses Thereof
App 20140051727 - Glick; Gary D. ;   et al.
2014-02-20
Therapeutic Applications Of Pro-apoptotic Benzodiazepines
App 20140038947 - Glick; Gary D. ;   et al.
2014-02-06
1,4-benzodiazepinone compounds and their use in treating cancer
Grant 8,604,023 - Glick , et al. December 10, 2
2013-12-10
Pyrazolyl Guanidine F1f0-atpase Inhibitors And Therapeutic Uses Thereof
App 20130324536 - Glick; Gary D. ;   et al.
2013-12-05
Benzodiazepinone Compounds Useful In The Treatment Of Skin Conditions
App 20130274197 - Glick; Gary D.
2013-10-17
Novel 1,4-benzodiazepine-2,5-diones With Therapeutic Properties
App 20130261110 - Glick; Gary D.
2013-10-03
Aryl guanidine F.sub.1F.sub.0-ATPase inhibitors and related methods
Grant 8,497,307 - Glick , et al. July 30, 2
2013-07-30
Compositions And Methods For Inhibiting The Proliferation Of Cells
App 20130190300 - Glick; Gary D. ;   et al.
2013-07-25
Benzodiazepinone compounds useful in the treatment of skin conditions
Grant 8,461,153 - Glick June 11, 2
2013-06-11
Compositions and methods for inhibiting the proliferation of cells
Grant 8,415,343 - Glick , et al. April 9, 2
2013-04-09
F.sub.1F.sub.0-ATPase inhibitors and related methods
Grant 8,324,258 - Glick , et al. December 4, 2
2012-12-04
Compositions And Methods Relating To Novel Compounds And Targets Thereof
App 20120289498 - Glick; Gary D.
2012-11-15
1,4-benzodiazepine-2,5-diones And Related Compounds With Therapeutic Properties
App 20120283229 - Glick; Gary D.
2012-11-08
1,4-benzodiazepine-2,5-diones And Related Compounds With Therapeutic Properties
App 20120270862 - Glick; Gary D.
2012-10-25
Benzodiazepinone Compounds And Methods Of Treatment Using Same
App 20120232067 - Glick; Gary D. ;   et al.
2012-09-13
Compositions And Methods Relating To Novel Compounds And Targets Thereof
App 20120214801 - Glick; Gary D.
2012-08-23
Compositions and methods relating to novel compounds and targets thereof
Grant 8,242,109 - Glick August 14, 2
2012-08-14
Benzodiazepine Compositions For Treating Epidermal Hyperplasia And Related Disorders
App 20120165301 - Glick; Gary D.
2012-06-28
Benzodiazepinone compounds useful in the treatment of skin conditions
Grant 8,188,072 - Glick May 29, 2
2012-05-29
Benzodiazepine compositions for treating epidermal hyperplasia and related disorders
Grant 8,168,626 - Glick May 1, 2
2012-05-01
1,4-benzodiazepinone Compounds And Their Use In Treating Cancer
App 20120094982 - Glick; Gary D. ;   et al.
2012-04-19
Novel 1,4-benzodiazepine-2,5-diones With Therapeutic Properties
App 20120088757 - Glick; Gary D.
2012-04-12
Unsolvated Benzodiazepine Compositions And Methods
App 20120077805 - Glick; Gary D. ;   et al.
2012-03-29
Benzodiazepinone Compounds Useful In The Treatment Of Skin Conditions
App 20120040971 - Glick; Gary D.
2012-02-16
Compositions and methods relating to novel compounds and targets thereof
Grant 8,097,612 - Glick January 17, 2
2012-01-17
1,4-benzodiazepine-2,5-diones with therapeutic properties
Grant 8,088,759 - Glick January 3, 2
2012-01-03
Aryl Guanidine F1f0-atpase Inhibitors And Related Methods
App 20110251200 - Glick; Gary D. ;   et al.
2011-10-13
Compositions And Methods Relating To Novel Compounds And Targets Thereof
App 20110195959 - Glick; Gary D.
2011-08-11
Unsolvated benzodiazepine compositions and methods
Grant 7,994,313 - Glick , et al. August 9, 2
2011-08-09
Compositions and methods relating to novel compounds and targets thereof
Grant 7,851,465 - Glick December 14, 2
2010-12-14
F1F0-ATPase Inhibitors and Related Methods
App 20100222400 - Glick; Gary D. ;   et al.
2010-09-02
Benzodiazepine Compositions For Treating Epidermal Hyperplasia And Related Disorders
App 20100222310 - Glick; Gary D.
2010-09-02
Benzodiazepine compositions for treating epidermal hyperplasia and related disorders
Grant 7,683,046 - Glick March 23, 2
2010-03-23
Compositions And Methods Relating To Novel Compounds And Targets Thereof
App 20100004227 - Glick; Gary D.
2010-01-07
Compositions and methods relating to novel benzodiazepine compounds and derivatives
Grant 7,638,624 - Glick December 29, 2
2009-12-29
Methods and compositions for treating diseases and conditions associated with mitochondrial function
App 20090275099 - Glick; Gary D.
2009-11-05
Unsolvated Benzodiazepine Compositions And Methods
App 20090253686 - Glick; Gary D. ;   et al.
2009-10-08
F1f0-atpase Inhibitors And Related Methods
App 20090203734 - Glick; Gary D.
2009-08-13
Compositions and methods relating to novel compounds and targets thereof
Grant 7,572,788 - Glick , et al. August 11, 2
2009-08-11
Benzodiazepinone Compounds Useful In The Treatment Of Skin Conditions
App 20090118244 - Glick; Gary D.
2009-05-07
Therapeutic applications of pro-apoptotic benzodiazepines
App 20090012065 - Glick; Gary D. ;   et al.
2009-01-08
Compositions and Methods Relating to Novel Compounds and Targets Thereof
App 20080293700 - Glick; Gary D.
2008-11-27
Compositions And Methods Relating To Novel Compounds And Targets Thereof
App 20080269194 - Glick; Gary D.
2008-10-30
Compositions And Methods Relating To Novel Compounds And Targets Thereof
App 20080269203 - Glick; Gary D.
2008-10-30
Compostions and methods relating to novel compounds and targets thereof
App 20070299059 - Glick; Gary D. ;   et al.
2007-12-27
Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
Grant 7,276,348 - Glick October 2, 2
2007-10-02
Compositions and methods relating to novel compounds and targets thereof
App 20070135418 - Glick; Gary D. ;   et al.
2007-06-14
Therapeutic application of pro-apoptotic benzodiazepines
Grant 7,220,739 - Glick , et al. May 22, 2
2007-05-22
Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
App 20070111994 - Glick; Gary D.
2007-05-17
Therapeutic compositions and methods
App 20070105844 - Glick; Gary D. ;   et al.
2007-05-10
Unsolvated benzodiazepine compositions and methods
App 20070043033 - Glick; Gary D. ;   et al.
2007-02-22
Therapeutic applications of pro-apoptotic benzodiazepines
App 20070036854 - Glick; Gary D. ;   et al.
2007-02-15
Compositions relating to novel compounds and targets thereof
Grant 7,144,880 - Glick December 5, 2
2006-12-05
Therapeutic applications of pro-apoptotic benzodiazepines
Grant 7,125,866 - Glick , et al. October 24, 2
2006-10-24
Compositions and methods relating to novel compounds and targets thereof
App 20060166975 - Glick; Gary D.
2006-07-27
Compositions and methods relating to novel compounds and targets thereof
App 20060052369 - Glick; Gary D.
2006-03-09
Compositions and methods relating to novel compounds and targets thereof
App 20060025388 - Glick; Gary D.
2006-02-02
Methods and compositions for treating diseases and conditions associated with mitochondrial function
App 20050272723 - Glick, Gary D.
2005-12-08
Compositions and methods relating to novel compounds and targets thereof
App 20050261176 - Glick, Gary D. ;   et al.
2005-11-24
Compositions and methods relating to novel compounds and targets thereof
App 20050113460 - Glick, Gary D.
2005-05-26
Compositions and methods relating to novel compounds and targets thereof
App 20040241781 - Glick, Gary D.
2004-12-02
Compositions relating to novel compounds and targets thereof
App 20040220180 - Glick, Gary D.
2004-11-04
Compositions and methods relating to novel compounds and targets thereof
App 20040176358 - Glick, Gary D.
2004-09-09
Compositions and methods relating to novel benzodiazepine compounds and targets thereof
App 20030119029 - Glick, Gary D. ;   et al.
2003-06-26
Therapeutic application of pro-apoptotic benzodiazepines
App 20010016583 - Glick, Gary D. ;   et al.
2001-08-23
Therapeutic methods for benzodiazepine derivatives
Grant 6,080,588 - Glick June 27, 2
2000-06-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed